Due Diligence

Due Diligence

The number of blockbuster drugs and products launched by pharmaceutical, biotechnology, and medical device industries continues to shrink. Small and large companies are realizing the need to get their compounds and/or devices through the development pipeline efficiently in order to capture the market share. This has forced companies to examine their compound portfolios and make strategic decisions based on whether or not to out-license compounds (or devices) or find an alliance partner for co-development. Some companies may develop a compound on their own in certain international markets while simultaneously out-licensing the compound to a partner who is better positioned to develop and launch that product in other regions.

Organizations often create alliances with partner companies, either through pharmaceutical product licensing or co-development, leading to faster ROI and greater success globally. Thus far, the management of these collaborative partnerships has been a challenge. Sharing the necessary documentation through "snail mail" or email is slow, costly and a security risk. To eliminate many of these costs and bring about greater efficiency, TransPerfect has developed Trial Interactive–the world's only clinical trial solution specifically designed to meet the needs of life sciences. Now, companies that are participating in licensing activities can securely share confidential product development information through an easy-to-use, web-based platform.

To find out more about how Trial Interactive can support your company's product licensing and alliance management efforts, contact us.



21 CFR Part 11

Contact us to learn more about our services

Contact Us